Skip to main content

and
  1. Article

    Open Access

    Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin

    Recombinant human soluble thrombomodulin (rTM) has been used for the treatment of disseminated intravascular coagulation in Japan, and an international phase III clinical trial for rTM is currently in progress...

    Takuro Arishima, Takashi Ito, Tomotsugu Yasuda, Nozomi Yashima in Thrombosis Journal (2018)